Discounted Cash Flow
Moderna, Inc.
—
—
Average annual growth rates
| Metric | 10-Year | 5-Year | 3-Year |
|---|---|---|---|
| Sales | — | — | — |
| Free Cash Flow | — | — | — |
| Average (FCF & NI) | — | — | — |
| Net Income | — | — | — |
Endpoint CAGR (better for long term trend)
| Metric | 10-Year | 5-Year | 3-Year |
|---|---|---|---|
| Sales | — | — | — |
| Free Cash Flow | — | — | — |
| Average (FCF & NI) | — | — | — |
| Net Income | — | — | — |
Projected growth rate
—
—
%
%
Historical inputs (10 fiscal years)
| YEAR | Sales | Net Income | Free Cash Flow | Net Margin | EPS (diluted) |
|---|---|---|---|---|---|
| 2017 | $205.8m | $-255.9m | $-389.9m | -124.3% | — |
| 2018 | $135.1m (-34.4%) | $-384.7m (-50.3%) | $-436.6m (-12.0%) | -284.8% (-129.1%) | — |
| 2019 | $60.2m (-55.4%) | $-514.0m (-33.6%) | $-490.5m (-12.3%) | -853.7% (-199.7%) | $-1.55 |
| 2020 | $803.4m (1234.3%) | $-747.1m (-45.3%) | $2.0b (499.5%) | -93.0% (89.1%) | $-1.96 (-26.3%) |
| 2021 | $18.5b (2199.1%) | $12.2b (1733.3%) | $13.3b (580.6%) | 66.1% (171.0%) | $30.28 (1644.2%) |
| 2022 | $19.3b (4.3%) | $8.4b (-31.5%) | $4.6b (-65.6%) | 43.4% (-34.3%) | $21.22 (-29.9%) |
| 2023 | $6.8b (-64.4%) | $-4.7b (-156.4%) | $-3.8b (-183.5%) | -68.8% (-258.6%) | $-12.34 (-158.1%) |
| 2024 | $3.2b (-52.7%) | $-3.6b (24.5%) | $-4.1b (-6.0%) | -110.0% (-59.9%) | $-9.27 (24.9%) |
| 2025 | $1.9b (-39.9%) | $-2.8b (20.8%) | $-2.1b (49.1%) | -145.2% (-31.9%) | $-7.25 (21.8%) |
Base FCF: — (latest fiscal year)
Discount rate: % —
Terminal growth: —
Projection period: — years
Alt A decline yrs:
Alt B total yrs:
Values abbreviated: b = billions, m = millions, k = thousands.
Projected cash flows
| Year | Projected cash flow | Discount Factor | Present Value |
|---|
PV of projected FCF: —
Terminal FCF: —
Terminal value: —
PV of terminal value: —
Enterprise value (DCF): —
Current price: —
—Alternative DCF Models
| Model | Fair Value | Upside | PV(FCFs) | PV(Terminal) | Total Years |
|---|---|---|---|---|---|
| Standard (10yr→TV) | — | — | — | — | 10 + TV |
| Alt A (Gradual Decline) | — | — | — | — | — |
| Alt B (30yr Hard Stop) | — | — | — | N/A | — |
This is a simplified DCF model for illustration. It uses reported free cash flow, a single growth assumption, fixed WACC, and a Gordon Growth terminal value. It is not investment advice.